SANGAMO BIOSCIENCES, INC.

Company

SANGAMO THERAPEUTICS, INC

Filed

August 9, 2013

Accession Number

0000902664-13-002793

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →